1-2 of 2
Salvador Macip
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-term follow-up of patients with CLL treated with the selective Bruton’s tyrosine kinase inhibitor ONO/GS-4059

Clinical Trials & Observations
Harriet S. Walter, Sandrine Jayne, Simon A. Rule, Guillaume Cartron, Franck Morschhauser, Salvador Macip, Lionel Karlin, Ceri Jones, Charles Herbaux, Philippe Quittet, Nimish Shah, Claire V. Hutchinson, Christopher Fegan, Yingsi Yang, Siddhartha Mitra, Gilles Salles, Martin J. S. Dyer
Journal: Blood
Blood (2017) 129 (20): 2808–2810.
https://doi.org/10.1182/blood-2017-02-765115
Published: 2017
Includes: Supplemental data
Journal Articles

Proliferating CLL Cells Express Abundant But Transcriptionally Compromised TP53 Protein

Jesvin J Samuel, BTech, MRes, Alice H Wignall, BSc, Hishyar Najeeb, BVMS, MSc, Aneela Majid, PhD, Sandrine Jayne, PhD, George D Jones, BSc, MSc, D.Phil., Salvador Macip, MD, PhD, Martin JS Dyer, MA, DPhil, FRCP, FRCPath
Journal: Blood
Blood (2013) 122 (21): 4134.
https://doi.org/10.1182/blood.V122.21.4134.4134
Published: 2013